| | TMZ Live Chad Johnson and Evelyn Lozada Bloody Pics After Domestic Violence ExNFL star Chad Johnson was scolded for taking his domestic violence case lightly in court ... and now we have photos of his exwife Evelyn Lozada face after the crime. News Chad Johnson Released From Jail Horrific and Bloody Evelyn Lozada Pic ... SOHH | |
| | Johnson and Johnson Rating Reiterated by Sterne Agee Johnson and Johnson logo Johnson and Johnson stock had its neutral rating reiterated by Sterne Agee in a research note issued on Monday Stock Ratings Network reports. | |
| | Johnson and Johnson Acquiring Aragon in Deal That Could Be Worth 1B Johnson and Johnson announced it will buy San Diegobased Aragon Pharmaceuticals Inc. for up to 1 billion. The privately held Aragon will receive an initial payment of 650 million and additional 350 million in milestone payments could follow from JandJ ... | |
| | Johnson and Johnson to buy Aragon Johnson and Johnson said Monday that it has agreed to buy Aragon Pharmaceuticals Inc. for at least 650 million in cash boosting its position in prostate drug development. | |
| | Johnson and Johnson And Aragon May Have Medivation Feeling Sick Seeking Alpha Jun 17 2013 The alreadysuccessful new prostate cancer drug Zytiga is not solely responsible for turning around the fortunes of Johnson and Johnson oncelackluster drug business but it has certainly played an important role. Johnson and Johnson is nownbsp... | |
| | Johnson and Johnson to buy Aragon for at least 650M The headquarters building of Johnson and Johnson stands in New Brunswick in this 2009 file photo. Johnson and Johnson said Monday that it has agreed to buy Aragon Pharmaceuticals Inc. for at least 650 million in cash boosting its position in prostate ... | |
| | Johnson and Johnson buys Aragon for 650M or more NEW BRUNSWICK N.J. Johnson and Johnson said Monday it has agreed to buy Aragon Pharmaceuticals Inc. for at least 650 million in cash boosting its position in prostate drug development. Johnson and Johnson to Buy Aragon Pharmaceuticals for 650 Million Up Front Motley Fool Johnson and Johnson And Aragon May Have Medivation Feeling Sick Seeking Alpha | |
| | Johnson and Johnson to Acquire Aragon Pharmaceuticals On Monday healthcare product company Johnson and Johnson announced that it will acquire Aragon Pharmaceuticals. Aragon which is a private company that is currently in a midstage clinical trial for a prostate cancer drug will be acquired by JNJ ... | |
| | Johnson and Johnson to buy Aragon in deal worth up to 1 billion Johnson and Johnson the world biggest maker of healthcare products agreed to buy Aragon Pharmaceuticals Inc. and its experimental prostate cancer drug in a deal worth as much as 1 billion. | |
| | Johnson and Johnson Announces Definitive Agreement To Acquire Aragon ... Sacramento Bee Jun 17 2013 NEW BRUNSWICK N.J. June 17 2013 PRNewswire Johnson and Johnson announced today a definitive agreement to acquire Aragon Pharmaceuticals Inc. a privatelyheld pharmaceutical discovery and development company focused onnbsp... | |
| | Johnson and Johnson to buy Aragon for up to 1 billion Johnson and Johnson said on Monday that it would buy Aragon Pharmaceuticals a private company that is running a midstage clinical trial for a prostate cancer drug for 650 million in cash upfront and a possible second payment of 350 million if it ... | |
| | JandJ in 1 billion deal to bolster prostatecancer focus Johnson and Johnson said it would pay up to 1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer to bolster JandJ role in the field after it acquired another experimental prostatecancer treatment four years ... | |
| | Johnson and Johnson Announces Definitive Agreement To Acquire Aragon ... NEW BRUNSWICK N.J. June 17 2013 PRNewswire Johnson and Johnson announced today a definitive agreement to acquire Aragon Pharmaceuticals Inc. a privatelyheld pharmaceutical discovery and development company focused onnbsp... | |
| | JandJ Depuy Synthes Wins 16 Million in Patent Case Johnson and Johnson DePuy Synthes unit a maker of artificial spinal repair products won 16 million in damages from Globus Medical Inc. when a jury decided that three of its patents were infringed. | |
| | Is Johnson and Johnson A Buy At These Prices Johnson and Johnson engages in the research and development manufacture and sale of various products in the healthcare field worldwide. | |
| |
0.78% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
